California State Teachers Retirement System (CalSTRS)’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-16,207
Closed -$306K 3077
2016
Q1
$306K Buy
16,207
+2,243
+16% +$43.2K ﹤0.01% 2688
2015
Q4
$371K Buy
13,964
+244
+2% +$8.47K ﹤0.01% 2608
2015
Q3
$626K Sell
13,720
-45
-0.3% -$1.7K ﹤0.01% 2273
2015
Q2
$443K Buy
13,765
+64
+0.5% +$1.86K ﹤0.01% 2645
2015
Q1
$436K Sell
13,701
-200
-1% -$6.77K ﹤0.01% 2537
2014
Q4
$525K Buy
13,901
+60
+0.4% +$1.65K ﹤0.01% 2459
2014
Q3
$365K Buy
13,841
+84
+0.6% +$2.22K ﹤0.01% 2625
2014
Q2
$407K Buy
13,757
+2,935
+27% +$94.9K ﹤0.01% 2625
2014
Q1
$400K Hold
10,822
﹤0.01% 2554
2013
Q4
$448K Buy
10,822
+60
+0.6% +$2.35K ﹤0.01% 2481
2013
Q3
$570K Buy
10,762
+342
+3% +$19.9K ﹤0.01% 2294
2013
Q2
$556K Buy
+10,420
New +$520K ﹤0.01% 2225

Other funds holding NAVB

California State Teachers Retirement System (CalSTRS)'s NAVB Position: Q2 2016 in Review

California State Teachers Retirement System (CalSTRS) sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q2 2016, closing a stake of 16,207 shares — an estimated $306K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in NAVB in Q2 2013 and held it in 12 quarters. The position peaked at $626K in Q3 2015. 63 funds tracked by Wall St. Rank hold NAVB as of Q2 2016.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Navidea Biopharmaceuticals Inc. position as of Q2 2016 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 16,207 Navidea Biopharmaceuticals Inc. shares in Q2 2016, an estimated $306K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and held it in 12 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Navidea Biopharmaceuticals Inc. position peaked at $626K in Q3 2015.
  • 63 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2016.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2016, filed 1 Aug 2016.